ICCC

ImmuCell Corporation (ICCC) Risks & Opportunities Analysis (2026)

Invetso Score: 6.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 6.4 (Moderate)

Long inventory cycles and a 159-day cash conversion cycle versus leaner peers can pressure working capital and limit flexibility if demand softens.

Net debt to EBITDA near 1.0x and interest coverage below 9x leave ICCC less insulated than cash-rich peers if rates stay elevated or earnings weaken.

A current ratio of 4.8x supports liquidity, but it also suggests capital is tied up in operating assets versus faster-turning peers, constraining efficiency.

Inventory intensity remains the main external risk because peers with shorter product cycles can respond faster to demand shifts and avoid obsolescence losses.

Absent disclosed free-cash-flow margin, ICCC’s peer-relative cash durability is harder to verify, which can widen valuation sensitivity when sector conditions tighten.

Opportunities

Score:

Strong liquidity and a quick ratio above 2.7x give ICCC more operating flexibility than many peers, supporting demand capture during cyclical volatility.

Moderate leverage at roughly 1.0x net debt to EBITDA leaves room to absorb working-capital swings better than more levered competitors.

Interest coverage near 9x is adequate versus weaker peers, reducing refinancing pressure and preserving capacity to fund growth when conditions improve.

High current assets can support service levels and inventory availability versus tighter-stock peers, which may help protect revenue in supply-constrained periods.

Overall Score

Score:

ICCC’s forward positioning is balanced by strong liquidity and manageable leverage, but long working-capital cycles and inventory intensity remain the main peer-relative constraints.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on ImmuCell Corporation. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →